These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

188 related articles for article (PubMed ID: 33096223)

  • 21. Hydroxychloroquine efficacy and safety in preventing SARS-CoV-2 infection and COVID-19 disease severity during pregnancy (COVID-Preg): a structured summary of a study protocol for a randomised placebo controlled trial.
    González R; García-Otero L; Pons-Duran C; Marbán-Castro E; Goncé A; Llurba E; Gil MDM; Rodríguez-Zambrano MÁ; Chen H; Ramírez M; Bardají A; Menendez C
    Trials; 2020 Jul; 21(1):607. PubMed ID: 32616063
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Impact of pantoprazole on absorption and disposition of hydroxychloroquine, a drug used in Corona Virus Disease-19 (Covid-19): A structured summary of a study protocol for a randomised controlled trial.
    Stoll F; Blank A; Mikus G; Czock D; Foerster KI; Hermann S; Häußler K; Muhareb A; Hummler S; Weiss J; Burhenne J; Haefeli WE
    Trials; 2020 Jun; 21(1):584. PubMed ID: 32600363
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Piechotta V; Chai KL; Valk SJ; Doree C; Monsef I; Wood EM; Lamikanra A; Kimber C; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Jul; 7(7):CD013600. PubMed ID: 32648959
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Chloroquine and its derivatives in the management of COVID-19: A scoping review.
    Pimentel J; Andersson N
    Biomedica; 2020 Oct; 40(Supl. 2):80-95. PubMed ID: 33152192
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A short, animated video to improve good COVID-19 hygiene practices: a structured summary of a study protocol for a randomized controlled trial.
    Vandormael A; Adam M; Greuel M; Bärnighausen T
    Trials; 2020 Jun; 21(1):469. PubMed ID: 32493460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The worldwide clinical trial research response to the COVID-19 pandemic - the first 100 days.
    Janiaud P; Axfors C; Van't Hooft J; Saccilotto R; Agarwal A; Appenzeller-Herzog C; Contopoulos-Ioannidis DG; Danchev V; Dirnagl U; Ewald H; Gartlehner G; Goodman SN; Haber NA; Ioannidis AD; Ioannidis JPA; Lythgoe MP; Ma W; Macleod M; Malički M; Meerpohl JJ; Min Y; Moher D; Nagavci B; Naudet F; Pauli-Magnus C; O'Sullivan JW; Riedel N; Roth JA; Sauermann M; Schandelmaier S; Schmitt AM; Speich B; Williamson PR; Hemkens LG
    F1000Res; 2020; 9():1193. PubMed ID: 33082937
    [No Abstract]   [Full Text] [Related]  

  • 27. Treatment with Hydroxychloroquine vs Hydroxychloroquine + Nitazoxanide in COVID-19 patients with risk factors for poor prognosis: A structured summary of a study protocol for a randomised controlled trial.
    Calderón JM; Zerón HM; Padmanabhan S
    Trials; 2020 Jun; 21(1):504. PubMed ID: 32513231
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Analysis of clinical and methodological characteristics of early COVID-19 treatment clinical trials: so much work, so many lost opportunities.
    Mainoli B; Machado T; Duarte GS; Prada L; Gonçalves N; Ferreira JJ; Costa J
    BMC Med Res Methodol; 2021 Feb; 21(1):42. PubMed ID: 33637044
    [TBL] [Abstract][Full Text] [Related]  

  • 29. COVID-19 Clinical Trials Registered Worldwide for Drug Intervention: An Overview and Characteristic Analysis.
    Wang B; Lai J; Yan X; Jin F; Yi B; An C; Li Y; Yao C
    Drug Des Devel Ther; 2020; 14():5097-5108. PubMed ID: 33239868
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Mortality outcomes with hydroxychloroquine and chloroquine in COVID-19 from an international collaborative meta-analysis of randomized trials.
    Axfors C; Schmitt AM; Janiaud P; Van't Hooft J; Abd-Elsalam S; Abdo EF; Abella BS; Akram J; Amaravadi RK; Angus DC; Arabi YM; Azhar S; Baden LR; Baker AW; Belkhir L; Benfield T; Berrevoets MAH; Chen CP; Chen TC; Cheng SH; Cheng CY; Chung WS; Cohen YZ; Cowan LN; Dalgard O; de Almeida E Val FF; de Lacerda MVG; de Melo GC; Derde L; Dubee V; Elfakir A; Gordon AC; Hernandez-Cardenas CM; Hills T; Hoepelman AIM; Huang YW; Igau B; Jin R; Jurado-Camacho F; Khan KS; Kremsner PG; Kreuels B; Kuo CY; Le T; Lin YC; Lin WP; Lin TH; Lyngbakken MN; McArthur C; McVerry BJ; Meza-Meneses P; Monteiro WM; Morpeth SC; Mourad A; Mulligan MJ; Murthy S; Naggie S; Narayanasamy S; Nichol A; Novack LA; O'Brien SM; Okeke NL; Perez L; Perez-Padilla R; Perrin L; Remigio-Luna A; Rivera-Martinez NE; Rockhold FW; Rodriguez-Llamazares S; Rolfe R; Rosa R; Røsjø H; Sampaio VS; Seto TB; Shahzad M; Soliman S; Stout JE; Thirion-Romero I; Troxel AB; Tseng TY; Turner NA; Ulrich RJ; Walsh SR; Webb SA; Weehuizen JM; Velinova M; Wong HL; Wrenn R; Zampieri FG; Zhong W; Moher D; Goodman SN; Ioannidis JPA; Hemkens LG
    Nat Commun; 2021 Apr; 12(1):2349. PubMed ID: 33859192
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Post-exposure prophylaxis or pre-emptive therapy for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2): study protocol for a pragmatic randomized-controlled trial.
    Lother SA; Abassi M; Agostinis A; Bangdiwala AS; Cheng MP; Drobot G; Engen N; Hullsiek KH; Kelly LE; Lee TC; Lofgren SM; MacKenzie LJ; Marten N; McDonald EG; Okafor EC; Pastick KA; Pullen MF; Rajasingham R; Schwartz I; Skipper CP; Turgeon AF; Zarychanski R; Boulware DR
    Can J Anaesth; 2020 Sep; 67(9):1201-1211. PubMed ID: 32383125
    [TBL] [Abstract][Full Text] [Related]  

  • 32. An evidence mapping and analysis of registered COVID-19 clinical trials in China.
    Lu L; Li F; Wen H; Ge S; Zeng J; Luo W; Wang L; Tang C; Xu N
    BMC Med; 2020 Jun; 18(1):167. PubMed ID: 32493331
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Characteristics of published/registered clinical trials on COVID-19 treatment: A systematic review.
    Asili P; Mirahmad M; Tabatabaei-Malazy O; Manayi A; Haghighat E; Mahdavi M; Larijani B
    Daru; 2021 Dec; 29(2):449-467. PubMed ID: 34762250
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Convalescent plasma or hyperimmune immunoglobulin for people with COVID-19: a living systematic review.
    Chai KL; Valk SJ; Piechotta V; Kimber C; Monsef I; Doree C; Wood EM; Lamikanra AA; Roberts DJ; McQuilten Z; So-Osman C; Estcourt LJ; Skoetz N
    Cochrane Database Syst Rev; 2020 Oct; 10():CD013600. PubMed ID: 33044747
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Hydroxychloroquine in the treatment of adult patients with Covid-19 infection in a primary care setting (LIBERTY): A structured summary of a study protocol for a randomised controlled trial.
    Vainio PJ; Hietasalo P; Koivisto AL; Kääriäinen S; Turunen J; Virtala M; Vuorinen J; Scheinin M
    Trials; 2021 Jan; 22(1):44. PubMed ID: 33430933
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Research methodology and characteristics of journal articles with original data, preprint articles and registered clinical trial protocols about COVID-19.
    Fidahic M; Nujic D; Runjic R; Civljak M; Markotic F; Lovric Makaric Z; Puljak L
    BMC Med Res Methodol; 2020 Jun; 20(1):161. PubMed ID: 32571302
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chemoprophylaxis trial designs in epidemics: insights from a systematic review of COVID-19 study registrations.
    Manoharan L; Olliaro P; Horby PW; Watson CH
    Trials; 2021 May; 22(1):370. PubMed ID: 34051840
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of Interferon Beta 1a, compared to Interferon Beta 1b and the usual therapeutic regimen to treat adults with moderate to severe COVID-19: structured summary of a study protocol for a randomized controlled trial.
    Irvani SSN; Golmohammadi M; Pourhoseingholi MA; Shokouhi S; Darazam IA
    Trials; 2020 Jun; 21(1):473. PubMed ID: 32493468
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Is it possible to conduct clinical trials during a pandemic? The example of a trial of hydroxychloroquine.
    Lilli C; Biggeri A; Zingaretti C; Vertogen B; Frassineti V; Vespignani R; Grossi V; Florescu C; Matteucci L; Pazzi C; Bongiovanni A; Limarzi F; Fausti V; Bertoni L; Donati C; Galardi F; Gentili N; Mazza F; Martinelli G; Nanni O
    Epidemiol Prev; 2021; 45(1-2):28-36. PubMed ID: 33884840
    [TBL] [Abstract][Full Text] [Related]  

  • 40. A Trial of Favipiravir and Hydroxychloroquine combination in Adults Hospitalized with moderate and severe Covid-19: A structured summary of a study protocol for a randomised controlled trial.
    Bosaeed M; Mahmoud E; Hussein M; Alharbi A; Alsaedy A; Alothman A; Aljeraisy M; Alqahtani H; Nashabat M; Almutairi B; Almaghaslah M; Aldibasi O; AlJohani S; Bouchama A; Arabi Y; Alaskar A
    Trials; 2020 Oct; 21(1):904. PubMed ID: 33129363
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.